Clinical Trial Update: GLP-1R Agonist Treatment for Opioid Use Disorder [Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 2 study of a GLP-1 receptor agonist for opioid use disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Opioid Use Disorder, Opioid Abuse and Addiction | Phase 2 | Status: RECRUITING